For research use only. Not for use in humans.

Fresolimumab (Anti-TGFb1)

Synonyms: GC1008

Fresolimumab (Anti-TGFb1) is a pan-specific, recombinant, fully human monoclonal antibody directed against human transforming growth factor (TGF) beta 1, 2, and 3 with potential antineoplastic activity. MW : 145.5 KD.

Fresolimumab (Anti-TGFb1)

Quality Control

Batch: Purity: 99% Protein concentration: 3.85mg/ml Endotoxin Level: <1EU/mg
99

Specificity

Name Citation ALK1 ALK2 ALK3 ALK4 TGFβRI/ALK5 ALK6 TGFβRII TGF-β Smad3 Others
SB431542 799
LDN-193189 262
Galunisertib (LY2157299) 192
LY2109761 137
SB-525334 116
SB505124 37
GW788388 25
LY364947 49 RIPK2,CK1δ,MLK-7K
RepSox (E-616452) 82
LDN-193189 Dihydrochloride 103
K02288 24
LDN-214117 4
SD-208 21
Vactosertib (TEW-7197) 28
ML347 5
LDN-212854 7
DMH1 61
Alantolactone 3 STAT3
SIS3 Hydrochloride 85
Hesperetin 4 Histamine receptor
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation.
2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description
Fresolimumab (Anti-TGFb1) is a pan-specific, recombinant, fully human monoclonal antibody directed against human transforming growth factor (TGF) beta 1, 2, and 3 with potential antineoplastic activity. MW : 145.5 KD.

Product Details

CAS No. 948564-73-6
Molecular Weight 145.5 kDa
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Sellecks selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.